Abstract:Background The acute leukemia of ambiguous lineage (ALAL) is high risk and uncommon in acute leukemia, including acute undifferentiated leukemia (AUL) and mixed phenotype acute leukemia (MPAL). On account of the rareness and age-influenced genome landscape, the genetic characterization was always limited and showed discrepancy among different cooperative groups. Methods By integrating the immunophenotype, cytogenetics, and molecular biology of ALAL patients, we found that the molecular profile played an important role in the diagnosis, treatment, and prognosis of ALAL patients. Through an in-depth analysis of the molecular features, we found the genetic differences between different subtypes of ALAL, and studied the unique gene mutation patterns and synergy of genomic abnormalities in different subtypes. Results Most patients in the cohort were children and young adults, and among B/myeloid and T/myeloid MPAL, while rare in AUL. Here we showed that ALAL patients show both genetic commonality and discrepancy among subtypes. Except for the BCR-ABL1 and KMT2A-r, which were mainly in B/myeloid MPAL, we reported that SET-NUP214 was recurrent in T/myeloid MPAL and AUL patients. The PHF6 were also frequently mutated in T/myeloid MPAL with most loss of function and significantly associated with SET-NUP214. Otherwise, there was a big difference between B/myeloid and T/myeloid MPAL in genetic profile. The most mutated genes in B/myeloid MPAL were CEBPA, RUNX1, NRAS, TET2, WT1, PTPN11, and FLT3, while NOTCH1, WT1, RUNX1, FLT3, PHF6, ETV6, and EZH2 were frequently in T/myeloid MPAL. Moreover, the alterations in the genes encoding transcriptional regulation were both recurrently mutated in B/myeloid and T/myeloid MPAL, especially WT1 and RUNX1, which were the most mutated genes and mutually exclusive with each other. Alterations in the genes involved in JAK_STAT signaling, RAS signaling, and epigenetic regulation were also recurrently mutated in B/myeloid and T/myeloid MPAL, despite some differences in incidence rate. However, the deletion of IKZF1 exclusively occurred in B/myeloid MPAL, while genes involved in NOTCH signaling were mainly altered in T/myeloid MPAL. When analyzing the synergy among genetic abnormalities, we found that SET-NUP214 and PHF6 (p = 0.00002), FLT3 and RUNX1 (p = 0.009), BCR-ABL1 and RUNX1 (p = 0.02) were the most significantly co-occurred genes (Figure 1-A, B). Although the association between NRAS and WT1 were not significantly (p = 0.11), they co-occurred in five patients (Figure 1-C). Since this was the first time to report that SET-NUP214 was recurrent in ALAL patients, we retrospectively review the therapy of patients with the aberration. According to the treatment of these ALAL patients, we confirmed that even with transplantation therapy the prognosis of SET-NUP214-positive ALAL patients was still very poor with a high risk of relapse. Discussion We charted the genomic landscape of ALAL to comprehensively reveal the commonality and discrepancy among subtypes of ALAL patients. The founding lesion of SET-NUP214 in early primitive hematopoietic cells was showed to be involved in the block of differentiation. Together with the loss of function in PHF6, which was showed a contribution to the lineage promiscuity and enhance the proliferation of hematopoietic cells, the combination event could make leukemia with ambiguous lineage. After deciphering the molecular characterization of ALAL patients, we proposed several candidate updates to WHO 2016 (Table 1), as these molecular features may help the diagnosis, therapy, and prognosis of the ALAL patients. Disclosures No relevant conflicts of interest to declare.

T-cell Acute Lymphoblastic Leukemia Associated with Complex Karyotype and SET-NUP214 Rearrangement: a Case Study and Review of the Literature.

B-Cell Acute Lymphoblastic Leukemia Associated with Set-Nup214 Rearrangement: A Case Report and Review of the Literature

Transient Pancytopenia Preceding Adult Acute Lymphoblastic Leukemia With Chromosomal Abnormalities Including The Philadelphia Chromosome: A Case Report And Review Of The Literature

Transcriptome-wide subtyping of pediatric and adult T cell acute lymphoblastic leukemia in an international study of 707 cases

[Analysis of the Clinical Characteristics of 24 Cases of Hematological Malignancies with SET-NUP214 Fusion Gene].

Therapy-Related Acute Lymphoblastic Leukemia Without 11q23 Abnormality Report Of Six Cases And A Literature Review

[Clinical Analysis of SET-NUP214 Fusion Gene Positive Patients with Acute Leukemia].

Determining the Appropriate Treatment for T-Cell Acute Lymphoblastic Leukemia With SET-CAN/NUP214 Fusion: Perspectives From a Case Report and Literature Review

Identification of Fusion Genes and Characterization of Transcriptome Features in T-cell Acute Lymphoblastic Leukemia.

Multidisciplinary Analysis of Pediatric T-ALL: 9q34 Gene Fusions

Clinical, Phenotypic and Molecular Characterization of NUP214-ABL1 Fusion Positive Myeloid Malignancies

A Novel NUP98/RARG Gene Fusion in Pediatric Acute Myeloid Leukemia Resembling Acute Promyelocytic Leukemia

Identification of Novel Fusion Genes and Characterization of Transcriptome Features in T-Cell Acute Lymphoblastic Leukemia

Two Childhood Cases of Acute Leukemia with T(16;21)(p11.2;q22): Second Case Report of Infantile Acute Lymphoblastic Leukemia with Unusual Type of FUS-ERG Chimeric Transcript

Deciphering Common Gene Fusions and Mutations in Acute Leukemia of Ambiguous Lineage

Cytogenetic Characteristics of Childhood Acute Lymphoblastic Leukemia: A Study of 1541 Chinese Patients Newly Diagnosed Between 2001 and 2014

CRLF2-rearranged B-cell ALL with extramedullary lineage switch to AML following CD19-targeted therapy

Therapy-related myeloid neoplasm in an 18-year-old boy with b-lymphoblastic leukemia.

Philadelphia chromosome-like acute lymphoblastic leukemia with concomitant rearrangements of CRLF2 and ABL1: a pediatric case report

T-Lymphoblastic Leukemia with T(9;22): Blast Phase of Chronic Myelogenous Leukemia or BCR-ABL- Positive T-Acute Lymphoblastic Leukemia?

[Study of the Childhood Acute Lymphoblastic Leukemia with T(12;21)].